Literature DB >> 28938525

Toxic effects of Tripterygium wilfordii Hook F on the reproductive system of adolescent male rats.

Xiaoping Jing1, Weiwei Cheng1, Sheng Guo1, Ya Zou1, Ting Zhang2, Li He3.   

Abstract

Tripterygium wilfordii Hook F. (TWHF) is a compound extracted from Lei Gong Teng (Thunder God Vine) that has been used to treat a variety of immune-related diseases in clinical practice, particularly in pediatrics. Nevertheless, clinical data indicated that glycosides from Tripterygium wilfordii Hook F (GTW) are toxic to the male reproductive system, but the mechanism is unknown. Here, the administration of a high dose of GTW for 4 weeks and a low dose for 12 weeks can reduce the body weights and testes weights in adolescent male rats. This effect is accompanied by a significantly reduction in the serum testosterone levels. Notably, short-term use of high-dose GTW or long-term use of low-dose GTW leads to testicular damage in adolescent male rats. Furthermore, the expression of the steroidogenic acute regulatory protein (StAR), P450 side chain cleavage enzyme (P450scc), cytochrome P450 17-hydroxylase (P450c17), 3β-hydroxysteroid dehydrogenase (3β-HSD), and 17β-hydroxysteroid dehydrogenase (17β-HSD) mRNAs and proteins in the testes was down-regulated by a short-term treatment with high-dose GTW and a long-term treatment with low-dose GTW. Therefore, GTW exhibit male reproductive toxicity in a concentration-and time-dependent manner by inhibiting the expression of the key enzymes and total cholesterol level involved in testosterone synthesis.
Copyright © 2017 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Adolescent; Male rats; Reproductive toxicity; TWHF

Mesh:

Substances:

Year:  2017        PMID: 28938525     DOI: 10.1016/j.biopha.2017.09.038

Source DB:  PubMed          Journal:  Biomed Pharmacother        ISSN: 0753-3322            Impact factor:   6.529


  2 in total

1.  Proteomic Study on the Reproductive Toxicity of Tripterygium Glycosides in Rats.

Authors:  Yanlin Dai; Lihui Sun; Shanshan Han; Shanshan Xu; Long Wang; Ying Ding
Journal:  Front Pharmacol       Date:  2022-05-20       Impact factor: 5.988

2.  Effectiveness and safety of KunXian capsule for the treatment of IgA nephropathy.

Authors:  Wei-Bo Le; Jin-Song Shi; Si-Wen Gong; Fan Yang
Journal:  BMC Nephrol       Date:  2022-05-10       Impact factor: 2.585

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.